Skip to content

May 16, 2026

ChatGPT Image May 7, 2026, 07_11_28 PM

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
Regulatory
Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings

Regulatory

Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings

Pharmaceutical Technology

The EMA's CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.

Regulatory Read full story

pharminent April 24, 2026 (Last updated: April 24, 2026)

Pharmaceutical Technology

The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.

Regulatory Read full story

Post navigation

Previous: Daiichi Sankyo shares slip after delaying annual earnings report

Next: Gene therapy leaders aim to help more Baby KJs with novel regulatory models

Related Stories

Regulatory

Biopharma industry endorses Pazdur for FDA commissioner role

pharminent May 15, 2026

Regulatory

With new data, Regenxbio to seek FDA approval of Duchenne gene therapy

pharminent May 14, 2026

Regulatory

Regulatory round-up: A month of key FDA approvals for cancer drugs

pharminent May 14, 2026

You May Have Missed

M&A / Deals

Arna Pharma and Slate Run complete JV for new US company

pharminent May 15, 2026

Commercial

Lilly UK recruits ex-England cricketer as obesity champion

pharminent May 15, 2026

Regulatory

Biopharma industry endorses Pazdur for FDA commissioner role

pharminent May 15, 2026

Clinical Data

ECO 2026: tirzepatide shows potential for T1D treatment

pharminent May 15, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.